Endoscopic Retrograde Cholangio-Pancreatography (ERCP) is used in what field?
Gallbladder cancer confused in the medical literature. Early diagnosis is not generally possible. People at high risk, such as women or Native Americans with gallstones, are evaluated closely. Transabdominal ultrasound, CT scan, endoscopic ultrasound, MRI, and MR cholangio-pancreatography (MRCP) can be used for diagnosis. A large number of gallbladder cancers are found incidentally in patients being evaluated for cholelithiasis, or gallstone formation, which is far more common. A biopsy is the only certain way to tell whether or not the tumorous growth is malignant. Xanthogranulomatous cholecystitis (XGC) is a rare form of gallbladder disease which mimics gallbladder cancer although it is not
Endoscopic ultrasound addition, the gastrointestinal wall itself can be imaged to see if it is abnormally thick, suggesting inflammation or malignancy. The technique is highly sensitive for detection of pancreatic cancer (90–95% sensitivity), particularly in patients who are suspected to have a mass or present with jaundice. Its role in staging patients with pancreatic cancer is limited to local metastases; however, in combination with CT scan which provides information on regional metastases, it provides an excellent imaging modality for diagnosis and staging of pancreatic carcinoma. Endoscopic ultrasound can also be used in conjunction with endoscopic retrograde cholangio pancreatography (ERCP). The ultrasound probe